Director Goodrich Katherine sold $183,384 worth of shares (2,954 units at $62.08) as part of a pre-agreed trading plan, decreasing direct ownership by 57% to 2,233 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

TARS· Tarsus Pharmaceuticals Inc.

Health Care

Original source

Director Goodrich Katherine sold $183,384 worth of shares (2,954 units at $62.08) as part of a pre-agreed trading plan, decreasing direct ownership by 57% to 2,233 units (SEC Form 4) | Quantisnow